cro.directory
← Compare landing

Aldeyra Therapeutics vs PCM Trials

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aldeyra/pcmtrials

CategoryAldeyra TherapeuticsPCM Trials
Listed sitecrocro
SummaryBiopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.World's largest independent, community-based clinical trial site network offering decentralized and mobile research services across diverse patient populations globally.
Services
  • Phase III Clinical Trials
  • Phase II Clinical Trials
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Immunology & Inflammation Services
  • Clinical Operations
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Immunology
  • Rare Disease
  • Ophthalmology
Data not yet provided.
LocationsData not yet provided.
  • Global Headquarters, Denver, Colorado, USA
  • Europe Regional Office, Slough, England, UK
  • Europe Regional Office, Losser, Overijssel, The Netherlands
  • Headquarters, Denver, Colorado, United States
  • Headquarters
CertificationsData not yet provided.
  • GCP · Identifier: Good Clinical Practice certified mobile research clinicians
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.